Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide as a nitric oxide synthase inhibitor and its structural development.

Rumiko Shimazawa1, Hiroko Sano, Aya Tanatani

  • 1Institute of Molecular & Cellular Biosciences, The University of Tokyo, Japan. shimazaw@nihs.go.jp

Chemical & Pharmaceutical Bulletin
|April 2, 2004
PubMed
Summary

Thalidomide shows weak nitric oxide synthase (NOS) inhibition. Analogs of thalidomide, specifically N-2,6-dimethylphenylhomophthalimide compounds, were developed and found to possess significant NOS-inhibiting activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of DNA-Encoded Libraries by Tryptophan-Selective Bioconjugation.

Organic letters·2026
Same author

Cooperative Chiral Induction in Aromatic <i>N</i>,<i>N</i>'-Dialkylated Urea Organocatalyst Enables Asymmetric Aza-Henry Reaction.

The Journal of organic chemistry·2026
Same author

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

Pharmacology research & perspectives·2026
Same author

On-DNA Platform Molecules Based on a Diazide Scaffold II: A Compact Diazide Platform Designed for Small-Molecule Drug Discovery.

International journal of molecular sciences·2026
Same author

Aromatic Amide Foldamers Show Conformation-Dependent Electronic Properties.

Chemphyschem : a European journal of chemical physics and physical chemistry·2025
Same author

Development of an On-DNA Platform Molecule Bearing a Diazidestructure and Its Application to DEL Synthesis.

International journal of molecular sciences·2025

Area of Science:

  • Medicinal Chemistry
  • Pharmacology

Background:

  • Thalidomide exhibits modest nitric oxide synthase (NOS) inhibitory effects.
  • Understanding the structure-activity relationship of thalidomide analogs is crucial for developing novel therapeutic agents.

Purpose of the Study:

  • To investigate the NOS-inhibitory activity of thalidomide analogs.
  • To explore N-2,6-dimethylphenylhomophthalimide derivatives for enhanced NOS inhibition.

Main Methods:

  • Synthesis of N-2,6-dimethylphenylhomophthalimide analogs.
  • Evaluation of nitric oxide synthase (NOS) inhibitory activity of synthesized compounds.

Main Results:

  • Thalidomide demonstrated weak NOS-inhibitory activity.
  • Several N-2,6-dimethylphenylhomophthalimide analogs exhibited potent NOS inhibition.

Related Experiment Videos

Conclusions:

  • N-2,6-dimethylphenylhomophthalimide derivatives represent a promising class of compounds for targeting NOS.
  • Further research into these analogs could lead to new therapeutic strategies involving NOS modulation.